Cargando…
Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
Patients with nonalcoholic fatty liver disease (NAFLD) are reported to have low growth hormone (GH) production and/or hepatic GH resistance. GH replacement can resolve the fatty liver condition in diet-induced obese rodents and in GH-deficient patients. However, it remains to be determined whether t...
Autores principales: | Cordoba-Chacon, Jose, Majumdar, Neena, List, Edward O., Diaz-Ruiz, Alberto, Frank, Stuart J., Manzano, Anna, Bartrons, Ramon, Puchowicz, Michelle, Kopchick, John J., Kineman, Rhonda D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542445/ https://www.ncbi.nlm.nih.gov/pubmed/26015548 http://dx.doi.org/10.2337/db15-0370 |
Ejemplares similares
-
Hepatic GH Receptor Signaling Directly Suppresses Hepatic Steatosis and De Novo Lipogenesis, Independent of Changes in Plasma IGF1 and Insulin
por: Vazquez Borrego, Maria del Carmen, et al.
Publicado: (2021) -
Growth Hormone Control of Hepatic Lipid Metabolism
por: Liu, Zhongbo, et al.
Publicado: (2016) -
Glucose Transporter 8 (GLUT8) Mediates Fructose-induced de Novo Lipogenesis and Macrosteatosis
por: DeBosch, Brian J., et al.
Publicado: (2014) -
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
por: Green, Charlotte J, et al.
Publicado: (2020) -
Skeletal Muscle Insulin Resistance Promotes Increased Hepatic De Novo Lipogenesis, Hyperlipidemia, and Hepatic Steatosis in the Elderly
por: Flannery, Clare, et al.
Publicado: (2012)